Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Credibility And Crying Wolf: US FDA Petition Guidance Says Past Practices Can Count Against You

Executive Summary

FDA is warning sponsors that a history of generic-delaying tactics may come back to haunt them when the agency considers whether a Citizen Petition is frivolous and potentially anti-competitive. But so will waiting too long to speak up.
Advertisement

Related Content

US FDA Amps Up "Name And Shame" Approach To Thwart Anti-Generic Tactics

Topics

Advertisement
UsernamePublicRestriction

Register

PS124043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel